Showing results (911-920 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|July 24, 2025
Sociodemographic factors predict outcomes and reveal spatial tumor patterns in glioblastomaPatrick H Luckett, Michael Olufawo, Noah Naddaff-Slocum, et al.
Neuro-Oncology Advances|July 28, 2025
Clinical integration and application of the 2022 WHO pituitary tumor classificationSylvia L Asa, Shereen Ezzat, Ozgur Mete
Neuro-Oncology Advances|July 28, 2025
Beyond the sella: Expanded endoscopic endonasal approaches for pituitary tumorsErion Junior de Andrade, Saira Alli, Raj Sindwani, et al.
Neuro-Oncology Advances|July 28, 2025
Mimickers of pituitary tumorsM Citlalli Perez-Guzman, Gabriela Szuman, Abdulrahman Altwijri, et al.
Neuro-Oncology Advances|July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between IDH tumor mutation and germline variantsMatthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
Neuro-Oncology Advances|June 27, 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safetyThomas Zeyen, Antonia Treiber, Matthias Schneider, et al.
Neuro-Oncology Advances|June 27, 2025
Molecular alterations in IDH-mutant astrocytoma: A multi-institutional retrospective studyKeng Lam, Hanim I Ozkizilkaya, Denái R Milton, et al.
Neuro-Oncology Advances|June 27, 2025
Identifying targetable alterations predictive of distant progression in glioblastoma patients undergoing standard therapyShivani Chiranth, Vincent Fougner, Ib Jarle Christensen, et al.
Neuro-Oncology Advances|June 27, 2025
Primary central nervous system lymphoma: Predictors of response to induction therapy and patterns of progressionLouis Cappelli, Allison Kayne, Jennifer Newman, et al.
Neuro-Oncology Advances|June 26, 2025
Deciphering the contributions of fecal microbiota from patients with high-grade glioma to tumor development in a humanized microbiome mouse model of gliomaCheng Wang, Yiqi Fan, Lu Zhang, et al.
Pageof 135